Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Ombrabulin

EU orphan designation number: EU/3/11/853
Active ingredient: Ombrabulin
Indication: Treatment of soft tissue sarcoma
Sponsor: Sanofi-Aventis groupe
54 rue La Boétie, 75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/04/2011 Orphan designation EMA/OD/141/10 (2011)2840 of 15/04/2011
06/11/2012 Change of name and/or address of sponsor EMA/OD/141/10
23/04/2014 Removal of orphan designation from Community Register